Sector valuations Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 23:00:00 14/07/2026 +03			5-day change	1st Jan Change
476.31 ^USD	-0.82%		-8.80%	+5.06%

07-13	American Academy of Orthopaedic Surgeons Launches New Pain Management Resource Center in Partnership with Curonix LLC Pacira Biosciences, Inc., Vertex Pharmaceuticals, and Viatris	CI
07-13	UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	27.4x	5.5x	1.9x	8.28x	18.68x	19.53x	-.--%	122B
ELI LILLY AND COMPANY	34.43x	21.05x	0.69x	12.54x	25.95x	26.79x	0.57%	1,054B
JOHNSON & JOHNSON	27.51x	6.92x	-1.83x	6.31x	17.15x	18.96x	2.07%	621B
ABBVIE INC.	30.73x	4502.54x	0.13x	7.36x	15.07x	15.56x	2.77%	438B
ROCHE HOLDING AG	17.67x	6.54x	1.06x	4.38x	10.82x	12.16x	3.03%	325B
NOVARTIS AG	21.42x	6.39x	-29.73x	5.5x	13.31x	14.55x	2.87%	281B
ASTRAZENECA PLC	21.07x	4.94x	0.94x	4.44x	12.4x	13.27x	1.98%	262B
NOVO NORDISK A/S	14.26x	6.28x	-11.48x	5.33x	10.96x	12.83x	3.5%	219B
AMGEN INC.	23.64x	18.19x	3.31x	6.27x	11.07x	14.34x	2.8%	195B
GILEAD SCIENCES, INC.	-47.34x	8.29x	0.34x	5.67x	31.3x	62.45x	2.47%	163B
PFIZER INC.	12.43x	1.59x	0.28x	3.06x	7.74x	8.73x	7.05%	140B
BRISTOL-MYERS SQUIBB COMPANY	11.65x	5.21x	0.25x	3.17x	8.45x	9.2x	4.24%	121B
GSK PLC	12.37x	4.5x	1.04x	2.75x	8.04x	9.1x	3.57%	104B
SANOFI	11.64x	1.23x	3.29x	2.18x	6.98x	7.95x	5.52%	106B
CHUGAI PHARMACEUTICAL CO., LTD.	23.39x	5.3x	1.36x	7.92x	14.97x	15.66x	1.89%	73.3B
BAYER AG	21.09x	1.75x	-0.13x	1.77x	8.41x	14.12x	0.46%	55.91B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	39.74x	5.38x	2.11x	9x	29.95x	30.85x	0.48%	54.26B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	43.24x	1.14x	52.86x	2.65x	9.76x	27.02x	3.84%	51.76B
HALEON PLC	18.85x	1.9x	4.02x	3.43x	12.86x	14.44x	2.19%	43.02B
ALNYLAM PHARMACEUTICALS, INC.	38.06x	18.09x	0.17x	6.35x	28.84x	28.03x	-.--%	38.46B
Average	20.16x	231.64x	1.53x	5.42x	15.14x	18.78x	2.56%	223.26B
Weighted average by Cap.	22.99x	451.17x	-1.35x	7.13x	17.04x	19.55x	2.25%

Other Pharmaceuticals

Stock Market
Stocks
VRTX Stock
Sector Vertex Pharmaceuticals Incorporated
Sector valuations

Google lets you customize your preferred sources.

Choose MarketScreener

×